HIV patient numbers increase among PCPs
Primary care providers are increasingly caring for and treating people living with HIV, according to a recent survey by HealthHIV.
PRIMARY CARE PROVIDERS are increasingly caring for and treating people living with HIV, according to a recent survey by HealthHIV, a nonprofit advocacy group.
HealthHIV surveyed nearly 1,200 primary care providers and HIV specialists. More than half (54%) of primary care respondents say they are treating HIV-positive patients and 43% said their HIV caseload has "increased" or "increased dramatically" during the past year.
The statistic doesn't come as a surprise to Sharon Lee, MD, a professor at the University of Kansas Medical Center and a primary care physician who has been treating HIV and AIDS patients for 25 years.
Like many aging patients, they're coping with chronic conditions, such as diabetes and heart disease, and they're already in the primary care system for those other medical problems, she says.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
